As we are now all aware, there were two main big problems with the Covid pandemic.
First, there was no way to identify which infected patients were going to do well, and which were more likely to end up in an ICU. This led to the absolute insanity of treating college students in their twenties the same as those in their seventies and eighties with vaccine mandates, forced isolation mandates, and nonsensical universal masking and spatial distancing.
If only there had been a simple way to identify those at high risk!
News flash from the Epoch Times:
“Chiba University in Japan recently announced the results of a new study that found that the severity of COVID-19 is highly correlated with the concentration of myosin light chain 9 (Myl9) protein in the blood. The findings could help hospitals determine which patient groups should be prioritized for admission and discharge, and thereby reduce the burden on the healthcare system.
A research team led by Chiba University Hospital announced on Aug. 1 that they published a study in the Proceedings of the National Academy of Sciences at the end of July that found the higher the concentration of Myl9 in the plasma of patients with COVID-19, the more severe the patient’s condition, and the longer the hospitalization time.”
Wow if this pans out … a likely Nobel Prize for the Japanese.
The second major problem was that there was no cheap, accepted treatment. “Go home. Pray and go to the hospital if you develop trouble breathing” did not inspire confidence with anybody. I have written many times about the success of Ivermectin in other countries around the world, but here in the U.S. Ivermectin was ‘persona non grata,’ because Dr. Fauci and the FDA said so … note that neither see any live patients!!
Well, Ivermectin, is back in the news. Actually, that’s not really true, as Ivermectin was never in the news because it was banned by the all knowing FDA. However the prodigious FDA did come out with a statement about Ivermectin that was fitting to that organization … “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”
Really! The fact that the “Food and Drug Administration” actually said that in August, 2021 tells me a lot about how seriously I should acknowledge what it says. Did I take Ivermectin when I tested positive for Covid? … No, I did not, mainly because to me it was just a bad cold. Did I have (and still have) Ivermectin? … Yes, although it was not prescribed for me. How did I get it? … MYOB!
To me, the fact that Ivermectin was persona-non-grata is an absolute folly. Ivermectin has been given to millions of people in Africa to treat “River Blindness,” and the side effects of that drug are minuscule! Is it useful in treating Covid? … I do not know, but I do know that in many countries there have been impressive statistics that suggest that it is very useful for Covid. However, Dr. Fauci and the FDA have maintained that the usefulness of Ivermectin in Covid has not been proven in a controlled double-blind study … possibly true, but unrelated to the real issue, which is whether or not the FDA has either the right or the authority to prevent physicians from using drugs for off-label illnesses. FYI: Physicians use drugs for off-label treatments all of the time. Why was Ivermectin singled out?? … To me this FDA decision was obviously political – the patients be damned! Although at this point the use of Ivermectin to treat Covid seems be like shutting the barn door after the horses have already gotten out, finally this issue will be settled in court.
From the Epoch Times:
In a lawsuit filed June 2, Drs. Robert L. Apter, Mary Talley Bowden and Paul E. Marik argued the FDA acted outside of its authority by directing the public, including health professionals and patients, to not use ivermectin — even though the drug is fully approved by the FDA for human use.
The suit, filed in the U.S. District Court, Southern District of Texas, Galveston Division, also names the U.S. Department of Health and Human Services (HHS), HHS Secretary Xavier Becerra and Robert Califf, acting FDA commissioner.
According to the complaint:
“The FDA generally cannot ban particular uses of human drugs once they are otherwise approved and admitted to the market, even if such use differs from the labeling — commonly referred to as ‘off-label’ use.
“The FDA also can not advise whether a patient should take an approved drug for a particular purpose. Those decisions fall within the scope of the doctor-patient relationship.
“Attempts by the FDA to influence or intervene in the doctor-patient relationship amount to interference with the practice of medicine, the regulation of which is — and always has been — reserved to states.”
The plaintiffs said their lawsuit isn’t about whether ivermectin is an effective treatment for COVID-19. It’s about who determines the appropriate treatment for each unique patient and whether the FDA can interfere with that process.
I fully agree with the merits of this suit, and hope that the plaintiffs are successful. I will be following this lawsuit as best I can, as assuredly you will not be reading about it or otherwise hearing about it in the Main Stream Media.
8/24/22